MétaCan
Menu
Back to cohort
Record W4409418010 · doi:10.1016/j.xjmad.2025.100121

An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression

2025· article· en· W4409418010 on OpenAlexaff
Charles R. Conway, A. John Rush, Charles M. Gordon, Sheldon Preskorn, Harold A. Sackeïm, Scott T. Aaronson, Roger S. McIntyre, Ying-Chieh Lee, Olivia Shy, Quyen Tran, J.M. Way, Mark Bunker

Bibliographic record

VenueJournal of Mood and Anxiety Disorders · 2025
Typearticle
Languageen
FieldMedicine
TopicTreatment of Major Depression
Canadian institutionsUniversity of Toronto
FundersDell Medical School, University of Texas at AustinCenters for Medicare and Medicaid ServicesStony Brook UniversityMcGovern Medical SchoolLivaNovaUniversity of AlabamaTexas Tech University Health Sciences CenterOhio State UniversityRush UniversitySchool of Medicine, Southern Illinois UniversityUniversity of California, San DiegoCarilion ClinicAugusta UniversityUniversity of MissouriIcahn School of Medicine at Mount SinaiUniversity of South CarolinaMassachusetts General HospitalUniversity of MinnesotaTexas Tech UniversityUniversity of Wisconsin-MadisonUniversity of UtahPerelman School of Medicine, University of PennsylvaniaMedical University of South CarolinaEmory UniversityUniversity of Pennsylvania
KeywordsDepression (economics)Quality of life (healthcare)Outcome (game theory)Function (biology)PsychologyConjoint analysisClinical psychologyMedicinePsychiatryPsychotherapistPreferenceMathematicsStatisticsEconomicsMicroeconomics

Abstract

fetched live from OpenAlex

Objective The treatment of depression aims to improve depressive symptoms, daily function and quality of life (QoL). These exploratory analyses of a database of convenience from the RECOVER trial evaluated how a "tripartite" metric based on these 3 outcome domains might perform in treatment-resistant depression (TRD). Methods Outcome domains included depressive symptoms (MADRS, QIDS-C, QIDS-SR), function (WPAI item-6) and QoL (Mini-Q-LES-Q) obtained at months 3, 6, 9 and 12 in outpatients with markedly TRD in the double-blind RECOVER trial that compared sham to active adjunctive vagus nerve stimulation (VNS). For each domain, clinically meaningful differences were defined a priori . Analyses addressed 3 questions: 1) Does each domain detect meaningful benefits undetected by the other domains? 2) Is the tripartite metric validated by an independent clinician-rated global index of improvement (CGI-I)? 3) How well does the tripartite metric detect treatment group differences in the RECOVER trial? Results Clinically meaningful reductions in depressive symptoms alone missed 25–51 % of all participants who evidenced clinically meaningful benefits in depressive symptoms, function or QoL. The tripartite metric strongly correlated with CGI-I ratings (tetrachoric r = 0.73–0.85), with stronger relationships than each component individually. The tripartite metric successfully separated active from sham adjunctive VNS in a 1-year trial of patients with markedly TRD. Conclusion Symptoms, function and QoL capture distinct, clinically significant and valid outcomes that identify persons with markedly TRD with a range of clinically meaningful benefits. Whether these results pertain to other major depressive disorder patient groups and treatments deserves study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.108
Threshold uncertainty score0.357

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.032
GPT teacher head0.373
Teacher spread0.340 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Mood and Anxiety DisordersSame topicTreatment of Major DepressionFrench-language works237,207